Dr. Robert Joseph Wallerstein, MD

Dr. Wallerstein practices at UCSF Benioff Children's Hospital Oakland in Oakland, California, part of University of California Health.

Dr. Wallerstein's NPI, 1285696203, was assigned on April 5, 2006. Dr. Wallerstein graduated from Rutgers Robert Wood Johnson Medical School in 1991. Dr. Wallerstein holds California license G88350.

Dr. Wallerstein's primary practice is UCSF Benioff Children's Hospital Oakland, at 747 52nd Street, Oakland, CA 94609 in Alameda County. The practice phone is (510) 428-3000.

Dr. Wallerstein's primary practice is UCSF Benioff Children's Hospital Oakland in Oakland, California, part of University of California Health. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Wallerstein to 3 more medical groups, 1 group practice or clinic and 1 school health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wallerstein practices, 3 sites in all. Vendor and product names are available with a free account.

Pediatrics is Dr. Wallerstein's primary specialty in the NPI Registry, under taxonomy code 208000000X. Dr. Wallerstein is board certified in clinical cytogenetics and genomics by the American Board of Medical Genetics and Genomics. Dmand AI has Dr. Wallerstein's licenses on file in 5 states: California, New York, New Jersey, Hawaii and Pennsylvania.

Dmand AI lists fluid and electrolyte imbalances, hypercalcemia and intellectual and developmental disabilities among the conditions Dr. Wallerstein treats.

CMS data shows 11 Medicare services from Dr. Wallerstein across 1 procedure code in 2024, all of them office visits, for 20 Medicare patients. Medicare paid $1,263 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 20 Medicare patients who saw Dr. Wallerstein in 2024. 65% of them have high cholesterol. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wallerstein's median patient age at 10, with 40% women.

In 2021, Dr. Wallerstein wrote 12 Medicare Part D claims. They cover 1 drug, with $365,519 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Wallerstein for performance year 2024, reported as part of a group. Dr. Wallerstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 70 papers to Dr. Wallerstein, published from 2006 to 2025. 2015 was the busiest year, with 5. The most frequent topics are Abnormalities, Multiple, Genetic Counseling and Karyotyping. Dr. Wallerstein has published most often in Clin Dysmorphol. Dr. Wallerstein's most frequent co-authors are Matthew J. Garabedian, MD, John Matthew Sum, MD and Javier E. Aisenberg, MD.

Dmand AI links Dr. Wallerstein to 1 clinical trial. Conditions studied include Mucopolysaccharidosis IV and Mucopolysaccharidoses.

CMS Open Payments shows 8 general payments to Dr. Wallerstein from 2 drug and device companies from 2018 to 2022. Food and beverage make up the largest share, 63% of the total. Sobi, Inc paid the most, $41.

Dr. Wallerstein graduated from Rutgers Robert Wood Johnson Medical School in 1991.

Dr. Wallerstein is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.